Author:
Sanchez-Lugo Yessica E.,Perez-Trujillo Jose J.,Gutierrez-Puente Yolanda,Garcia-Garcia Aracely,Rodriguez-Rocha Humberto,Barboza-Quintana Oralia,Muñoz-Maldonado Gerardo E.,Saucedo-Cardenas Odila,de Oca-Luna Roberto Montes,Loera-Arias Maria J.
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Biotechnology,Bioengineering,Applied Microbiology and Biotechnology
Reference19 articles.
1. Cairns CM, Gordon JR, Li F et al (2001) Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor. J Immunol Baltim Md 1950 167:57–65
2. Cheng W-F, Hung C-F, Chai C-Y et al (2001) Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 108:669–678
3. Dufour JH, Dziejman M, Liu MT et al (2002) IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168:3195–3204. doi: 10.4049/jimmunol.168.7.3195
4. Gattinoni L, Powell DJ, Rosenberg SA, Restifo NP (2006) Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6:383–393
5. Gomez-Gutierrez JG, Elpek KG, de Oca-Luna RM et al (2007) Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice. Cancer Immunol Immunother CII 56:997–1007
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献